Video & Transcript Research : 'FDA'
Page 30 of 62
FL
Florida 2026 4th Special Session
January 27, 2026 - 12:30 PM
Transcript Highlights:
- For more than a decade, the FDA Foundation has hosted the Florida Mission of Mercy, which provided 17,000
- Jeffrey Otley, FDA, in opposition. Brandon Edmonson in opposition.
Summary:
The committee first heard HB 245, which would replace references in Florida law to “child pornography” with “child sexual abuse material.” The sponsor said the change was overdue and more accurately reflects the criminal nature of the material. There was brief supportive public testimony, no debate, and the bill was reported favorably on a unanimous vote.
The committee then took up HB 237 on the use of professional nursing titles. The sponsor said advanced practice registered nurses should be able to use earned academic titles such as DNP or PhD. Supporters testified in favor, there was no opposition or debate, and the bill passed unanimously and was reported favorably.
The longest discussion centered on HB 173, which would expand parental consent and access requirements for minors’ medical care, medical records, certain school surveys, and biomedical devices. Supporters argued it restores parental rights and keeps parents involved in children’s health decisions, while opponents—many from medical, mental health, LGBTQ, and youth advocacy groups—warned it could block access to STI treatment, mental health care, crisis hotlines, and confidential services for vulnerable youth, including those in abusive homes. After extensive testimony and debate, the bill was reported favorably on a 19-7 vote.
Finally, the committee began HB 327 on uterine fibroid research. The sponsor explained the bill would require health care providers to submit identified data so the Department of Health can build a usable de-identified research database, after prior implementation problems with duplicate or unverified data. A supportive local official testified, and members indicated support as the meeting moved toward a vote.
TX
Texas 89th Regular
Senate Committee on Health and Human Services (Part I) Apr 9th, 2025
Health & Human Services
Transcript Highlights:
- Food and Drug Administration, or FDA.
- experimental or investigational, or under administration by the Emergency Use Authorization by the FDA
Bills:
SB227, SB269, SB407, SB463, SB527, SB547, SB1283, SB1380, SB1383, SB1511, SB1640, SB1784, SB2069
Keywords:
school funding, education reform, state budget, property taxes, equity in education, healthcare policy, vaccines, exemptions, religious beliefs, public health, workplace violence, healthcare facilities, definition expansion, safety regulations, health and safety code, health insurance, anesthesia, pediatric dental services, coverage, medical necessity
NM
Transcript Highlights:
- So far, the FDA has not taken responsibility to regulate it.
- Unfortunately, the FDA has not taken a stand on making sure that these products are managed, and so this
TX
Transcript Highlights:
- action against relative to practices that fell outside what TMB was being directed. ...to do by FSMB, FDA
- We don't receive any directions from FSMB, the FDA, or the CDC.
US
US Federal 2025-2026 Regular Session
Hearings to examine the poisoning of America, focusing on fentanyl, its analogues, and the need for permanent class scheduling. Feb 4th, 2025 at 09:30 am
Senate Judiciary
Transcript Highlights:
- very agencies and organizations representing academic scientific research, including the NIH, HHS, FDA
- So then that's why they supported NIH, HHS, FDA.
MN
Minnesota 2025-2026 Regular Session
Committee on Agriculture, Veterans, Broadband and Rural Development - 03/18/26
Agriculture, Veterans, Broadband, and Rural Development
Transcript Highlights:
- eggs to hunger relief organizations once they are past their quality assurance date, even though the FDA
- eggs to hunger relief organizations once they are past their quality assurance date, even though the FDA
- :52.280>
the quality assurance date, even though the quality assurance date, even though the FDA - 03:53.520>
that <01:03:53.720>eggs <01:03:53.960>are <01:03:54.080>food FDA - guidelines state that eggs are food FDA guidelines state that eggs are food safe<01:03:54.800>
for
MN
Minnesota 2025-2026 Regular Session
House Environment and Natural Resources Finance and Policy Committee 2/19/26
Environment and Natural Resources Finance and Policy
Transcript Highlights:
- saw fit to exempt medical devices, recognizing both the rigorous federal oversight provided by the FDA
- companies invest years and significant resources to research, develop, patent, test, and then secure FDA
- 02.640>
secure develop patent test and then to secure develop patent test and then to secure FDA - 03.920>
for <00:48:04.079>devices <00:48:04.480>that <00:48:04.720>improve FDA - clearance for devices that improve FDA clearance for devices that improve and<00:48:05.599>
save<
KY
Kentucky 2025 Regular Session
Make America Healthy Again Kentucky Task Force (8-20-25)
Transcript Highlights:
- You’ve got a study here from 1998 from the FDA about sucralose.
- from<00:19:34.160>
1998 <00:19:35.200>from <00:19:35.440>the <00:19:35.679>FDA - <00:19:36.400>
about study here from 1998 from the FDA about study here from 1998 from the - FDA about sucralose.<00:19:37.679>
You've <00:19:37.840>got <00:19:38.320>2011 - So to have FDA right there is concerning to me because, as you mentioned, 95% of the 2020 studies—the
Summary:
The task force met for its third meeting, approved the minutes, and heard testimony from Dr. Jack on behalf of the American Beverage Association and Kentucky Beverage Association. Dr. Jack argued that the “totality of the science” supports low- and no-calorie sweeteners as safe and useful tools for reducing sugar and calories, citing FDA and other domestic and international reviews, clinical trials, and the FDA’s recent healthy-label rule. He also described the industry’s transparency efforts, including a “Good to Know” database compiling ingredient and safety information, and said the beverage industry has voluntarily worked to offer more choices with less sugar.
Members questioned him about whether beverage ingredients are restricted in other countries, possible health effects beyond weight and cancer, concerns about metabolic issues and gut microbiome effects, whether sweeteners are addictive, and why companies do not simply remove sweeteners. Dr. Jack responded that most ingredients are permitted in many jurisdictions, that broad food-safety reviews have looked at multiple endpoints and found the ingredients safe, that the gut microbiome is still being studied, and that recent clinical evidence does not show increased sweetness preference. He also said business decisions about formulations are up to companies and noted that cane sugar and high-fructose corn syrup are metabolically similar.
The committee also discussed consumer apps and ingredient-scoring tools; Dr. Jack said the industry’s website presents facts without interpretation and is based on food-safety agency assessments. At the end of his testimony, the chair accepted additional fact sheets for the committee. The meeting then moved on to introduce Dr. Gary Huber, who began testimony by emphasizing integrative medicine, metabolic syndrome, and the role of diet, exercise, sleep, and stress in health, but his full presentation was not included in the excerpt.
NH
Transcript Highlights:
- Does it repeal laws that limit abortion, chemical abortions, no later than 10 weeks, even though the FDA
- Does it repeal laws that limit abortion, chemical abortions, no later than 10 weeks, even though the FDA
- weeks<01:24:14.440>
even <01:24:14.639>though <01:24:14.800>the <01:24:14.960>FDA - 01:24:15.440>
has <01:24:15.600>found <01:24:15.880>that weeks even though the FDA - has found that weeks even though the FDA has found that thousands<01:24:16.480>
of <01:24:16.639
NH
New Hampshire 2025 Regular Session
Senate Health and Human Services (01/15/2025)
Health and Human Services
Transcript Highlights:
- Some of the more recognizable drugs on here: Humira, 311 patents, 287 of those patents come after FDA
- Kuda, also recognizable from the television ads, 180 patents, 11 of them after FDA approval, and the
- those patents Humera 311 patents 287 of those patents come<01:26:46.480>
after <01:26:46.840>FDA - come after FDA come after FDA approval<01:26:49.679>
Kuda <01:26:50.639>also <01:26
ND
North Dakota 2026 1st Special Session
Senate Floor Session Jan 22nd, 2026 at 08:30 am
North Dakota Senate Floor Meeting
Transcript Highlights:
- antipsychotics, chemotherapy agents, Schedule II controlled substances, biological products, which are just the FDA
Keywords:
SB 2401, North Dakota, Century Code, occupational therapy, occupational therapy board, criminal history record check, background check, licensee investigation, physician continuing education, medical license renewal, nutrition education, metabolic health, chronic disease prevention, health occupation boards, medical board, licensure fee, audit response, disciplinary action, Title 43, board of medicine
Summary:
The Senate convened with prayer, the Pledge of Allegiance, and a quorum present. It adopted the procedural employment committee report naming Senate staff for the special session. The chamber then took up several health-care and appropriations measures, first adopting amendments to Senate Bills 2401, 2402, and 2403 before moving them to final passage.
Senate Bill 2401 passed 44-2 and requires physicians to complete at least one hour of continuing education in nutrition and metabolic health, part of a broader rural health care package. Senate Bill 2402 passed 46-0 after major amendments negotiated between the medical and pharmacy boards; as amended, it expands pharmacists’ prescriptive authority and therapeutic substitution in limited areas while excluding categories such as antidepressants, antipsychotics, chemotherapy agents, Schedule II drugs, biological products, and narrow therapeutic index drugs. Supporters said it would improve rural access and help secure rural health transformation funding, while questions focused on how pharmacist competence would be measured and enforced.
Senate Bill 2403, also passed 46-0, creates a short-term medical facility emergency operating loan program through the Bank of North Dakota, reduced by amendment from $10 million to $5 million, to help a financially distressed rural hospital. Senators discussed the hospital’s mismanagement, the need for a bridge loan, and safeguards including a limited application window and expiration in 2027. Senate Bill 2404 passed 46-0 and provides supplemental appropriations to the Information Technology Department for ADA-related website accessibility compliance and to the Public Service Commission for additional legal costs in federal energy-rate litigation. The Senate then made announcements about a Highway Patrol safety presentation and filing deadlines, excused an absent member, and adjourned until the next morning.
FL
Florida 2026 5th Special Session
Regulated Industries Jan 12th, 2026
Transcript Highlights:
- Recent FDA rulings pertaining to exactly this VPA issue have confirmed that in each instance a licensed
Summary:
The Committee on Regulated Industries met with a quorum and took up two bills. First, it considered SB 754 on heated tobacco products. The sponsor said the bill would define heated tobacco products and exempt them from the cigarette tax, arguing they are a less harmful alternative for nicotine users. Senators asked about youth access and regulation, and the sponsor said he would research those issues further. A representative of the Florida Retail Federation appeared in support, and the committee voted the bill favorably.
The committee then heard SB 796 on veterinary medicine, after adopting a delete-everything amendment. The amended bill would create a Veterinary Professional Associate (VPA) role, allowing individuals with a master’s degree and national competency exam to perform certain delegated veterinary tasks under a licensed veterinarian’s responsible supervision. It also expanded the allowable period for telehealth prescriptions for flea and tick products and other medications. Supporters said the bill would expand access to care, reduce costs, and help address veterinary shortages, while opponents from the Florida Veterinary Medical Association argued the proposal was unnecessary, could create safety and federal-law concerns, and that existing veterinary technicians and other workforce measures were a better solution. After testimony and debate, the amendment was adopted and the bill was reported favorably.
During final debate, several senators said the VPA proposal was more limited and better balanced than earlier versions, with the veterinarian retaining liability and control over delegated duties. The sponsor closed by emphasizing rising veterinary costs, shortages of care, and the need for more affordable access for pet owners. The committee then adjourned.
ND
North Dakota 2025-2026 Regular Session
Senate Appropriations - Government Operations Division Apr 3rd, 2025 at 09:30 am
Appropriations - Government Operations Division
Transcript Highlights:
- So, and we did hear yesterday that there are 34 products that have been approved by the FDA, not 10.
Bills:
SB2012
Summary:
The Government Operations Division met to continue work on budget and bill amendments. The committee first took up the Attorney General’s budget and reviewed a detailed amendment package that adjusted FTE levels, salary equity funding, funding sources, and several one-time appropriations. Changes included removing some House-added items, adding contingent funding tied to other bills, restoring certain funding sources, increasing the electronic smoking device manufacturer fee, and adding a provision on 24/7 sobriety program fees. Senator Dwyer then offered a further amendment to make the electronic smoking device fee a $2,000 application fee with a $500 annual renewal fee, which passed. The committee then voted 4-1 to adopt the budget as amended and give it a do pass recommendation as amended.
The committee next considered House Bill 1143, relating to Great Plains Food Bank funding. After testimony from Amy Cleary on behalf of Great Plains Food Bank, members discussed the organization’s statewide role and the project’s financing, including a planned $30 million facility and existing fundraising. Senator Burkhard moved to restore the appropriation from $5 million to $10 million, and the motion passed 4-1. The committee then voted 4-1 to give the bill a do pass recommendation as amended, with Senator Burkhard designated as carrier.
Finally, the committee discussed House Bill 1524, which would fund regional planning councils and authorize 16 FTEs. Members expressed sympathy for the councils’ work but concerns about approving new state-funded positions. No action was taken, and the chair asked to hold the bill over for further review. The committee then recessed, noting remaining budget work and upcoming hearings.
NH
New Hampshire 2026 Regular Session
House Environment and Agriculture (03/31/2026)
Environment and Agriculture
Transcript Highlights:
- something that is not universal in all—it's a somewhat more questionable category according to the FDA
- something that is not universal in all—it's a somewhat more questionable category according to the FDA
- something that is not universal in all—it's a somewhat more questionable category according to the FDA
- something that is not universal in all—it's a somewhat more questionable category according to the FDA
- something that is not universal in all—it's a somewhat more questionable category according to the FDA
ND
North Dakota 2025-2026 Regular Session
Health Care Committee Jul 15th, 2026
Transcript Highlights:
- rating scales, et cetera, opioids for the last 30 years, like I said, have been the only approved or FDA-approved
- But in that space, opioids for the last 30 years, like I said, have been the only approved or FDA-approved
- Khan, so I know this has only been FDA approved for, I mean, just shy of 18 months probably now.
Summary:
The committee first approved the previous meeting minutes and then heard a detailed annual report from Dr. Thomas Arnold, chair of the Maternal Mortality Review Committee, on maternal mortality trends and policy issues. He explained the committee’s review process, confidentiality protections, and national and North Dakota data showing that most maternal deaths are preventable and that mental health conditions, substance use, cardiovascular issues, infection, hemorrhage, and embolism are the leading causes. Members asked about suicide, domestic violence, midwife training, home births, and whether pregnancy testing at death scenes should be expanded; Dr. Arnold said better coroner education, more investigation of unexplained deaths, and possible post-mortem pregnancy testing could improve case identification, especially in rural areas. He also noted that deaths often occur well after 42 days postpartum and that mental health-related deaths remain a major concern.
The committee then heard from State Fire Marshal Dr. Matthew Clark on cigarette reduced-ignition-propensity standards and related fire prevention issues. He recommended updating the state’s cigarette propensity law to current national standards and also raised a separate recommendation to require fast-breakaway oxygen tubing for home oxygen users, citing fatal fires linked to smoking around oxygen. Members asked about implementation, cost, insurance coverage, and whether the standards apply in tribal communities; Dr. Clark said he would provide follow-up information and was willing to help with any legislation, but no agency bill had yet been planned.
Next, Christine Greff of the Department of Health and Human Services reported on the North Dakota Stroke System of Care. She described the statewide network of stroke-ready hospitals, registry-based quality improvement, and performance data showing continued improvement in stroke recognition, imaging, thrombolytic treatment, transfers, and EMS pre-notification. She highlighted new quality measures for inter-facility transfers and intracerebral hemorrhage care, and said the system remains strong but depends on continued legislative and hospital support. Committee members asked about participation by the VA hospital and were encouraged to consider outreach to include it more fully in the stroke system.
Finally, the committee began a presentation on prior authorization and non-opioid pain treatment from Taha Khan of Vertex Pharmaceuticals. He argued that prior authorization can delay access to non-opioid acute pain medications, especially in the 24- to 72-hour post-discharge window when pain is most severe, and said delays can push patients toward opioids. He emphasized that prior authorization has a role in utilization management but should not create barriers in acute pain care, and he noted that current use of the company’s non-opioid product remains very low. The discussion was still underway when the transcript ended.
MA
Massachusetts 2025-2026 Regular Session
Joint Committee on the Judiciary Jun 21st, 2026 at 01:00 pm
Joint Committee on the Judiciary
Transcript Highlights:
- The FDA conducted testing on 30 of the most popular brands of kratom and found disturbingly high levels
- From 2008 to 2019, I lived in the grip of FDA-approved pain pills, benzos, and muscle relaxers prescribed
- From 2008 to 2019, I lived in the grip of FDA approved paint pills, benzos, and muscle relaxers prescribed
- Misty Brown continued: “I lived in the grip of FDA-approved pain pills, benzos, and muscle relaxers prescribed
Summary:
The Joint Committee on the Judiciary held a lengthy hearing on several juvenile justice and parole-related bills, with much of the testimony focused on H. 2051/S. 1087 to end lifetime parole for juveniles and emerging adults, and H. 1923 to raise the age of juvenile court jurisdiction to include 18-, 19-, and 20-year-olds. Chairs Brandy Fluker-Reid and Lydia Edwards opened the hearing by noting the large number of bills and witnesses, the need to keep testimony moving, and special procedures for incarcerated witnesses and sensitive testimony. They also acknowledged the historic nature of the hearing being chaired by two Black women attorneys. No votes were taken during the hearing itself.
Many incarcerated speakers and advocates supported ending lifetime parole, arguing that young people can change, that lifetime supervision creates constant fear of technical violations, and that it undermines rehabilitation, family stability, employment, and reintegration. Several testified about their own trauma, youth, and growth in prison programs, while others emphasized the costs of decades of supervision and the racial disparities in the system. Support also came from elected officials, UTEC, the Transformational Prison Project, United Way, CPCS’s Youth Advocacy Division, the Massachusetts Coalition to Prevent Gun Violence, and others, who said juvenile systems are better suited to developmentally appropriate treatment and that the bills would improve public safety and reduce recidivism.
There was also opposition, including testimony from family members of a murder victim who argued that lifetime parole should remain for serious violent crimes and that some offenders are not sufficiently rehabilitated. One virtual witness described a family tragedy involving the kidnapping and murder of her infant nephew and warned that ending lifetime parole could remove needed long-term supervision for dangerous offenders. In addition to the juvenile justice bills, the committee heard testimony on H. 1867, a bill related to continuing care for severe mental illness, and H. 2063, which would increase penalties for assaults on correction officers and other prison staff; the correction officers’ union supported H. 2063 and related safety bills. The hearing continued with many more witnesses and bill topics, but no final committee action was announced in the portion provided.
KY
Kentucky 2026 Regular Session
Interim Joint Committee on Natural Resources & Energy.(6-4-26)
Natural Resources & Energy
Transcript Highlights:
- But, you know, the EPA, the FDA, and the USDA are all studying PFAS.
- know,<01:09:24.560>
the <01:09:24.799>EPA, <01:09:25.759>the <01:09:26.000>FDA - <01:09:26.719>
and <01:09:26.960>the <01:09:27.199>USDA you know, the EPA, the FDA - , and the USDA you know, the EPA, the FDA, and the USDA are<01:09:28.400>
all <01:09:28.719>
CO
Colorado 2026 Regular Session
Colorado Senate 2026 Legislative Day 113 May 7th, 2026
Colorado Senate Floor Meeting
Transcript Highlights:
- There are now FDA-approved treatments that can help manage symptoms and improve quality of life for many
- There are now FDA<01:09:04.400>
approved <01:09:04.799>treatments <01:09:05.359>that - <01:09:05.600>
can <01:09:05.759>help FDA approved treatments that can help FDA approved
Summary:
The Senate convened with a quorum, approved the journal, and received a series of engrossing/revising/enrolling notices and committee reports. Committee reports advanced several measures, including House Bills 1139 and 1263 from Business, Labor, and Technology; House Bills 1206, 1111, and 1014 from Finance; and later Appropriations reports on House Bills 1423, 1419, 1276, 1256, 1015, and Senate Bills 189, 188, 187, 180, and 125. The chamber also granted a brief recess for guests and later granted leave for the Joint Budget Committee to meet while the Senate was in session.
A major portion of the meeting was devoted to tributes and personal privilege remarks. Senators recognized the University of Denver men’s hockey team for winning the 2026 NCAA championship and adopted a joint Senate-House tribute honoring the team’s 11th national title. Senator Kolker also marked Tardive Dyskinesia Awareness Day/Week, describing the condition, the need for screening and treatment, and honoring a guest advocate living with TD.
The Senate then moved through third-reading consent and final-passage votes on multiple bills. Measures passed included SB 181, HB 1338, HB 1344, HB 1336, HB 1227, HB 1314, HB 1282, HB 1317, HB 1078, SB 167, HB 1069, HB 1132, HB 1347, HB 1210, HB 1196, HB 1224, and HB 1028; HB 1028 was first removed from the consent calendar, amended with a conforming amendment, and then passed. Several bills drew notable opposition, including HB 1132 and HB 1210, while HB 1069 passed unanimously. The Senate also laid over the general order second-reading calendar to Friday, May 8, 2026, and took up special-order second-reading bills in committee of the whole, adopting the special-order consent calendar and reporting those bills back favorably for further consideration.
US
US Federal 2025-2026 Regular Session
US House Floor Proceedings (Thursday, April 30, 2026)
US Federal House Floor Meeting
Transcript Highlights:
- congressman on honey regulation through congressman on honey regulation through the<00:49:39.760>
FDA - :49:41.440>
to <00:49:41.599>vote <00:49:41.839>no <00:49:42.079>on the FDA - But I will have to vote no on the FDA.
- trusted exporters and the minority would be happy to work with the majority on honey regulation through FDA
NH
New Hampshire 2026 Regular Session
Senate Executive Departments and Administration (04/22/2026)
Executive Departments and Administration
Transcript Highlights:
- We asked them to enable our local state agencies, instead of FDA being sent to New Hampshire to oversee
- enable<00:05:00.440>
our <00:05:01.080>instead <00:05:01.480>of <00:05:01.600>FDA - <00:05:02.240>
being <00:05:02.960>sending enable our instead of FDA being sending - enable our instead of FDA being sending employees<00:05:04.080>
to <00:05:04.200>New <00